Health
Johnson & Johnson COVID-19 vaccine candidate demonstrates robust protection in pre-clinical studies – manilastandard.net
Johnson Johnson announced that its lead vaccine candidate for COVID-19 elicited a robust immune response as demonstrated by neutralizing antibodies in pre-clinical studies.
6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines
Trunklines: 832-5554, 832-5556, 832-5558…
Continue Reading
-
Noosa News19 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business22 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News21 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General20 hours agoInternal Revenue Service starts cutting 20,000 workers